VanEck Associates
ETNB

VanEck Associates’s 89bio ETNB Stock Holding History

VanEck Associates’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,315
Closed -$78K – 1292
2021
Q1 		$78K Buy
3,315
+49
+2% +$1.13K ﹤0.01% 1037
2020
Q4 		$80K Buy
3,266
+1,518
+87% +$38.8K ﹤0.01% 931
2020
Q3 		$45K Buy
1,748
+37
+2% +$1.17K ﹤0.01% 944
2020
Q2 		$34K Buy
+1,711
New +$41.6K ﹤0.01% 934

Other funds holding ETNB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

VanEck Associates's ETNB Position: Q2 2021 in Review

VanEck Associates sold out of 89bio (ETNB) in Q2 2021, closing a stake of 3,315 shares — an estimated $78K sold.

VanEck Associates first reported a position in ETNB in Q2 2020 and held it in 4 quarters. The position peaked at $80K in Q4 2020. 49 funds tracked by Wall St. Rank hold ETNB as of Q2 2021.

  • VanEck Associates reported no remaining 89bio position as of Q2 2021 after selling out during the quarter.
  • VanEck Associates sold 3,315 89bio shares in Q2 2021, an estimated $78K.
  • VanEck Associates first reported a position in 89bio in Q2 2020 and held it in 4 quarters.
  • VanEck Associates's 89bio position peaked at $80K in Q4 2020.
  • 49 funds tracked by Wall St. Rank held 89bio as of Q2 2021.

Based on VanEck Associates's 13F filing for Q2 2021, filed 10 Aug 2021.